SK5122003A3 - A combination comprising camptothecin and a stilbene derivative for the treatment of cancer - Google Patents

A combination comprising camptothecin and a stilbene derivative for the treatment of cancer Download PDF

Info

Publication number
SK5122003A3
SK5122003A3 SK512-2003A SK5122003A SK5122003A3 SK 5122003 A3 SK5122003 A3 SK 5122003A3 SK 5122003 A SK5122003 A SK 5122003A SK 5122003 A3 SK5122003 A3 SK 5122003A3
Authority
SK
Slovakia
Prior art keywords
combretastatin
cpt
combination
administered
treatment
Prior art date
Application number
SK512-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SK5122003A3 publication Critical patent/SK5122003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK512-2003A 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer SK5122003A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24343100P 2000-10-27 2000-10-27
US24558200P 2000-11-06 2000-11-06
US25013800P 2000-12-01 2000-12-01
PCT/EP2001/012985 WO2002034244A2 (en) 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Publications (1)

Publication Number Publication Date
SK5122003A3 true SK5122003A3 (en) 2003-12-02

Family

ID=27399663

Family Applications (1)

Application Number Title Priority Date Filing Date
SK512-2003A SK5122003A3 (en) 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Country Status (22)

Country Link
US (1) US6562834B2 (bg)
EP (1) EP1333820A2 (bg)
JP (1) JP2004517821A (bg)
KR (1) KR100742524B1 (bg)
CN (1) CN1200712C (bg)
AU (2) AU1602902A (bg)
BG (1) BG107806A (bg)
BR (1) BR0114856A (bg)
CA (1) CA2426898A1 (bg)
EA (1) EA005400B1 (bg)
EE (1) EE200300184A (bg)
HK (1) HK1058623A1 (bg)
HR (1) HRP20030382A2 (bg)
HU (1) HUP0302629A3 (bg)
IL (1) IL155509A0 (bg)
MX (1) MXPA03002882A (bg)
NO (1) NO324844B1 (bg)
NZ (1) NZ524855A (bg)
PL (1) PL365685A1 (bg)
SK (1) SK5122003A3 (bg)
WO (1) WO2002034244A2 (bg)
YU (1) YU29803A (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183266A1 (en) * 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
US7850990B2 (en) * 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
TW200819409A (en) 2006-10-19 2008-05-01 Univ Taipei Medical Z-stilbenes derivatives and the pharmaceutical composition thereof
CN110015962B (zh) 2011-01-28 2022-03-15 肯塔基大学研究基金会 茋类似物和治疗癌症的方法
WO2013003112A1 (en) 2011-06-27 2013-01-03 The Jackson Laboratory Methods and compositions for treatment of cancer and autoimmune disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116015A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Antitumor agent
JPS57116074A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154582A (ja) 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS595188A (ja) 1982-06-30 1984-01-12 Yakult Honsha Co Ltd １０−ヒドロキシカンプトテシンの製造法
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JP2524804B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体及びその製造法
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
EP0540099B1 (en) 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
TW334418B (en) 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5663177A (en) 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5670500A (en) 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
DK1251125T3 (da) 1995-06-21 2006-04-18 Sod Conseils Rech Applic Hidtil ukendte camptothecin-analoger, fremgangsmåde til fremstilling heraf, anvendelse heraf som lægemidler og farmaceutiske præparater indeholdende disse
JP3054669B2 (ja) 1995-10-16 2000-06-19 余川商事株式会社 積雪落下防止装置
JPH11296051A (ja) 1998-04-08 1999-10-29 Canon Inc プロセスカートリッジ
PT1144011E (pt) * 1998-12-11 2010-06-16 Coulter Pharm Inc Compostos pró-fármacos e processo para a sua preparação
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
CA2432792C (en) 2000-12-22 2012-04-03 Bristol-Myers Squibb Company Methods for modulating tumor growth and metastasis

Also Published As

Publication number Publication date
YU29803A (sh) 2006-05-25
MXPA03002882A (es) 2004-12-03
NO20031656D0 (no) 2003-04-10
US6562834B2 (en) 2003-05-13
KR100742524B1 (ko) 2007-08-02
NO324844B1 (no) 2007-12-17
EA200300516A1 (ru) 2003-08-28
CN1200712C (zh) 2005-05-11
NZ524855A (en) 2004-10-29
CA2426898A1 (en) 2002-05-02
KR20030082544A (ko) 2003-10-22
AU1602902A (en) 2002-05-06
NO20031656L (no) 2003-04-10
IL155509A0 (en) 2003-11-23
AU2002216029B2 (en) 2006-01-05
US20020115677A1 (en) 2002-08-22
HRP20030382A2 (en) 2005-04-30
EE200300184A (et) 2003-08-15
WO2002034244A2 (en) 2002-05-02
BR0114856A (pt) 2004-06-15
EA005400B1 (ru) 2005-02-24
WO2002034244A3 (en) 2003-05-30
PL365685A1 (en) 2005-01-10
HUP0302629A2 (hu) 2003-11-28
BG107806A (bg) 2004-06-30
EP1333820A2 (en) 2003-08-13
CN1471396A (zh) 2004-01-28
HUP0302629A3 (en) 2005-05-30
HK1058623A1 (en) 2004-05-28
JP2004517821A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
RU2429838C2 (ru) Комбинированная химиотерапия
JP2009263371A (ja) 抗癌組み合わせ
JP2001517250A (ja) ナフタレンスルホン酸誘導体を含有する相乗作用抗腫瘍組成物
AU785467B2 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
WO1999048503A1 (en) Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
PL205728B1 (pl) Kombinacja zawierająca kombretastatynę i czynniki przeciwnowotworowe
EP1201247B1 (en) Treatment of metastatic renal cell carcinoma
SK5122003A3 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
JP2706371B2 (ja) 癌治療用補助剤及びそれを用いたキット
WO2012075754A1 (zh) 一种治疗急性淋巴白血病的复方药物组合物
AU2002216029A1 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
KR100879712B1 (ko) 탁산과 사이클린-의존성 키나제 억제제와의 병용제제
US6548488B2 (en) Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
KR20010075074A (ko) 간 종양을 치료하기 위한 메톡시모르폴리노 독소루비신의용도
US20030195161A1 (en) Composition comprising camptothecin or a camptothecin derivative and a topoisomerase II inhibitor for the treatment of cancer
ZA200302552B (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer.
PL200504B1 (pl) Kompozycja farmaceutyczna zawierająca pochodną dystamycyny, produkt zawierający pochodną dystamycyny oraz zastosowanie pochodnej dystamycyny
RU2284818C2 (ru) Комбинированная химиотерапия
KR20010102402A (ko) 상승작용성 항종양 조성물
WO2004073719A1 (en) A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
EP1716852A1 (en) A composition comprising campothecin or a campothecin derivative and an alkylating agent for the treatment of cancer

Legal Events

Date Code Title Description
FC9A Refused patent application